FORTIS COLLEGE PHARMACOLOGY EXAM 2
2026 ACTUAL EXAM PAPER QUESTIONS WITH
SOLUTIONS GRADED A+
◉ Heparin lab test.
Answer: aPTT
◉ Heparin antidote.
Answer: Protamine sulfate
◉ Warfarin (Coumadin).
Answer: Long-term anticoagulant
◉ Warfarin lab test.
Answer: INR
◉ Warfarin antidote.
Answer: Vitamin K
◉ Aspirin.
Answer: Prevents platelet aggregation and prevents arterial clots
,◉ Clopidogrel.
Answer: Prevents platelets from sticking
◉ Alteplase (tPA).
Answer: BREAKS DOWN clots
◉ Anticoagulants.
Answer: Prevent clots
◉ Antiplatelets.
Answer: Stop platelets
◉ Thrombolytics.
Answer: BREAK clots
◉ Common risk for all coagulation drugs.
Answer: Risk of bleeding
◉ Heparin administration route.
Answer: IV
, ◉ Major risks of Heparin.
Answer: Bleeding and HIT (induced thrombocytopenia)
◉ Clinical uses for Alteplase (tPA).
Answer: Stroke, MI, PE
◉ Patient teaching for coagulation therapy.
Answer: Use soft toothbrush, avoid injury, report bleeding
immediately
◉ Labs to check before Thrombolytic therapy.
Answer: INR, aPTT, Platelets
◉ Goal of hematopoietic drugs.
Answer: Stimulate blood cell production, improve immune response,
and treat anemia, infection risk, and immune dysfunction
◉ Epoetin alfa.
Answer: Mimics erythropoietin and stimulates RBC production
◉ Epoetin alfa clinical uses.
Answer: Anemia (especially CKD, chemo)
2026 ACTUAL EXAM PAPER QUESTIONS WITH
SOLUTIONS GRADED A+
◉ Heparin lab test.
Answer: aPTT
◉ Heparin antidote.
Answer: Protamine sulfate
◉ Warfarin (Coumadin).
Answer: Long-term anticoagulant
◉ Warfarin lab test.
Answer: INR
◉ Warfarin antidote.
Answer: Vitamin K
◉ Aspirin.
Answer: Prevents platelet aggregation and prevents arterial clots
,◉ Clopidogrel.
Answer: Prevents platelets from sticking
◉ Alteplase (tPA).
Answer: BREAKS DOWN clots
◉ Anticoagulants.
Answer: Prevent clots
◉ Antiplatelets.
Answer: Stop platelets
◉ Thrombolytics.
Answer: BREAK clots
◉ Common risk for all coagulation drugs.
Answer: Risk of bleeding
◉ Heparin administration route.
Answer: IV
, ◉ Major risks of Heparin.
Answer: Bleeding and HIT (induced thrombocytopenia)
◉ Clinical uses for Alteplase (tPA).
Answer: Stroke, MI, PE
◉ Patient teaching for coagulation therapy.
Answer: Use soft toothbrush, avoid injury, report bleeding
immediately
◉ Labs to check before Thrombolytic therapy.
Answer: INR, aPTT, Platelets
◉ Goal of hematopoietic drugs.
Answer: Stimulate blood cell production, improve immune response,
and treat anemia, infection risk, and immune dysfunction
◉ Epoetin alfa.
Answer: Mimics erythropoietin and stimulates RBC production
◉ Epoetin alfa clinical uses.
Answer: Anemia (especially CKD, chemo)
